Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
基本信息
- 批准号:7237244
- 负责人:
- 金额:$ 195.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
This program is based on the hypothesis that salt-dependent hypertension involves the following sequence of events: Salt retention as a result of excessive intake or reduced renal excretion, leads to elevation of the endogenous ouabain (EO) level in plasma. EO, an adrenocortical hormone, selectively inhibits Na+ pumps with alpha2 or alpha3 subunits in neurons, artery myocytes and endothelial cells. Consequently, local intracellular Na+ concentrations rise at plasma membrane-sarco/endo-plasmic reticulum (PM-S/ER) junctions where these Na+ pumps are located. Then, via Na/Ca exchange (NCX), local Ca 2+signaling and Ca 2+storage are
augmented; in the chronic state, however, endothelium-dependent vasodilation may be suppressed. The net result is an increase in vasoconstriction, peripheral vascular resistance (PVR) and blood pressure. This hypothesis will be tested on isolated small arteries and myocytes from rats and mice. The studies are designed to elucidate the detailed mechanism of action of acute and chronic low dose ouabain treatment. The ouabain-hypertensive (OH) rat model, several transgenic mouse lines with altered PM ion transporters and transmitter receptors, and novel anti-ouabain agents and NCX blockers will be used. There are 4
projects and 2 cores. Project 1 will characterize the physiology and pharmacology of several key steps in smooth muscle within intact arteries, in the pathway from ouabain to increased PVR. Project 2 will focus on store-operated Ca 2+ entry and storage mechanisms in freshly isolated myocytes, and the effects of acute and chronic ouabain on these mechanisms which appear to be altered in OH. Project 3 will employ novel measurements of quantal content and Ca 2+ signaling to characterize details of sympathetic neuromuscular transmission in small arteries, and will determine how acute and chronic ouabain treatment influences these parameters. Project 4 will elucidate the effects of acute and chronic ouabain treatment on Ca 2+signaling in
endothelial cell and pericyte function in renal descending vasa recta and, based on preliminary data, will explore the apparent dysfunction of these signaling mechanisms in OH. The projects will be supported by animal model/analytic chemistry/biochemistry and imaging/electrophysiology/relational database cores. The results will elucidate the mechanism(s) by which ouabain alters Ca 2+ homeostasis, augments sympathetic neuromuscular transmission, influences endothelial feedback, and induces hypertension. This will provide insight into novel targets for anti-hypertensive therapy.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORDECAI P BLAUSTEIN其他文献
MORDECAI P BLAUSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORDECAI P BLAUSTEIN', 18)}}的其他基金
Alpha-2 Na+ Pumps, [Ca2+], Arterial Contraction & Hypertension
Alpha-2 Na 泵,[Ca2],动脉收缩
- 批准号:
8232831 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Alpha-2 Na+ Pumps, [Ca2+], Arterial Contraction & Hypertension
Alpha-2 Na 泵,[Ca2],动脉收缩
- 批准号:
8390477 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility & Quabain Hypertension
钠 , 钙 , 动脉收缩力
- 批准号:
7088889 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
- 批准号:
7644870 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
- 批准号:
7457710 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility & Ouabain Hypertension
钠 , 钙 , 动脉收缩力
- 批准号:
6855447 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别:
Ouabain, Local Ca2+ Control and Myogenic Tone
哇巴因、局部 Ca2 控制和肌源性张力
- 批准号:
6968172 - 财政年份:2004
- 资助金额:
$ 195.13万 - 项目类别:
PATHWAYS OF INSULIN AND IGFI RECEPTOR SIGNALING
胰岛素和 IGFI 受体信号传导途径
- 批准号:
2331471 - 财政年份:1996
- 资助金额:
$ 195.13万 - 项目类别:
相似国自然基金
缢蛏Gq-opsins介导光谱差异驱动Ca2+信号转导的机制研究
- 批准号:QN25C190011
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于IP3R/Ca2+信号轴研究肌醇干预中华鳖肠道紧密连接功能障碍的机制
- 批准号:QN25C190025
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
乳酸通过激活Ca2+/NFAT1轴驱动Treg细胞上调CCR8促进肿瘤进展的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
肠道菌群及代谢产物谷氨酸通过NMDAR/Ca2+/CaMKⅡ信号通路介导的神经元自噬调控神经发育障碍的机制研究
- 批准号:2025JJ80645
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于5-HT–[Ca2+]i–PKC信号通路研究葎草制剂通过改善炎症诱导的内质网应激和间隙连接抑制促进糖尿病足创口愈合的机制
- 批准号:JCZRLH202501287
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Ca2+促进亲脂弱酸性药物载入脂质体磷
脂双层膜的分子机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
NIR-II光敏剂调控Ca2+通道蛋白介导钙超载缓解肥厚型心肌病的光动力治疗研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Piezo1通过Ca2+/CaMKII信号轴调控线粒体稳态在心肌缺血再灌注损伤中的作用及机制研究
- 批准号:JCZRQN202500509
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
新型CCR2选择性抑制剂通过调控Ca2+/Fe2+通道蛋白MCU表达促进肝癌细胞铁死亡的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
可喷涂电活性水凝胶调控Ca2+依赖组蛋
白H3K18乳酸化促进脊髓损伤修复的机制
研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
相似海外基金
Na+/Ca2+ Exchanger type-1 in Arterial Contraction and Salt-induced Hypertension
Na /Ca2 交换器 1 型在动脉收缩和盐诱发高血压中的作用
- 批准号:
8452207 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Alpha-2 Na+ Pumps, [Ca2+], Arterial Contraction & Hypertension
Alpha-2 Na 泵,[Ca2],动脉收缩
- 批准号:
8232831 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Na+/Ca2+ Exchanger type-1 in Arterial Contraction and Salt-induced Hypertension
Na /Ca2 交换器 1 型在动脉收缩和盐诱发高血压中的作用
- 批准号:
8086544 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Na+/Ca2+ Exchanger type-1 in Arterial Contraction and Salt-induced Hypertension
Na /Ca2 交换器 1 型在动脉收缩和盐诱发高血压中的作用
- 批准号:
8645710 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Alpha-2 Na+ Pumps, [Ca2+], Arterial Contraction & Hypertension
Alpha-2 Na 泵,[Ca2],动脉收缩
- 批准号:
8390477 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Na+/Ca2+ Exchanger type-1 in Arterial Contraction and Salt-induced Hypertension
Na /Ca2 交换器 1 型在动脉收缩和盐诱发高血压中的作用
- 批准号:
8264976 - 财政年份:2011
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility & Quabain Hypertension
钠 , 钙 , 动脉收缩力
- 批准号:
7088889 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
- 批准号:
7644870 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
- 批准号:
7457710 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别:
Na+, Ca2+, Arterial Contractility & Ouabain Hypertension
钠 , 钙 , 动脉收缩力
- 批准号:
6855447 - 财政年份:2005
- 资助金额:
$ 195.13万 - 项目类别: